AAAS and the Food and Drug Law Institute (FDLI) are holding three 2-day meetings in Washington DC on personalized medicine, addressing the scientific discoveries, business models, and policy changes that are necessary to develop personalized treatments and diagnostics. All three meetings will be available via a free live webcast where viewers can use response technology to interact with speakers and session chairs.

